Picture Berlin Partner BIO 2024 International Convention San Diego 650x100px

Organisation › Details

Encycle Therapeutics Inc.

https://www.encycletherapeutics.com

LinkedIn: https://www.linkedin.com/company/encycle-therapeutics-inc

	Start	2012-01-01 established (s-off)
	Group	Zealand Pharma (Group)
	Predecessor	University of Toronto
	Industry	peptide-based drug
	Industry 2	ET3764 (Encycle Therapeutics)
	Person	Coull, Jeffrey (Encycle Therapeutics 201910 CEO)

	Region	Toronto, ON
	Country	Canada
	Street	101 College Street Suite 314
	City	ON M5G Toronto, ON
		Address record changed: 2020-12-02

Basic data	Employees	n. a.


		Record changed: 2023-07-10

Picture EBD Group World of Partnering Opportunities 650x200px

More documents for Zealand Pharma (Group)

[1] Zealand Pharma A/S. (3/30/22). "Press Release: Zealand Pharma Appoints New Chief Executive Officer, Refocuses Strategy to Prioritize Research & Development and Streamlines Operations". Copenhagen & Boston, MA....
[2] Zealand Pharma A/S. (10/22/19). "Press Release: Zealand Pharma Expands Its Peptide Platform with Acquisition of Encycle Therapeutics". Copenhagen....
[3] Step Pharma SAS. (9/6/19). "Press Release: Step Pharma Appoints Seasoned Drug Developer Dr. Andrew Parker as Chief Executive Officer". Paris....
[4] Modus Therapeutics AB. (3/11/19). "Press Release: Modus Therapeutics Strengthens Management Team with Appointment of Mats Blom, MBA as CFO". Stockholm....
[5] Zealand Pharma A/S. (10/1/18). "Press Release: Zealand Pharma Expands Leadership Team and Appoints Marino Garcia as Senior Vice President of Corporate & Business Development". Copenhagen....
[6] Zealand Pharma A/S. (8/15/17). "Press Release: Overallotment Option of 15% Has Been Exercised". Copenhagen....
[7] Zealand Pharma A/S. (8/14/17). "Press Release: Zealand Pharma A/S Has Today Registered a Capital Increase of 4,375,000 New Shares and Completed its Initial Public Offering of American Depositary Shares on the Nasdaq Global Select Market in the United Sta...
[8] Zealand Pharma A/S. (8/9/17). "Press Release: Zealand Pharma A/S Prices Its Initial Public Offering of American Depositary Shares on The Nasdaq Global Select Market in the United States". Copenhagen....
[9] Zealand Pharma A/S. (7/6/17). "Press Release: Zealand Pharma Files Registration Statement for Proposed Initial Public Offering of ADSs in the U.S.". Copenhagen....
[10] Zealand Pharma A/S. (7/3/17). "Press Release: Zealand Initiates First Phase 3 Trial with Dasiglucagon for the Treatment of Severe Hypoglycemia in Diabetes". Copenhagen....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]